Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has conducted its 5th board meeting for FY2024, where they approved a significant capital injection into Tianjin Pharmaceutical Group Taiping Medicine Co., Ltd. The board, in full attendance, also sanctioned a resultant joint venture and a substantial guarantee provision, both contingent on the completion of the capital injection and classified as interested person transactions.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.
